APA (7th ed.) Citation

B, V., NA, H., & H, K. (2024). Novel Bispecific T-Cell Engagers for the Treatment of Relapsed B Cell Non-Hodgkin Lymphomas: Current Knowledge and Treatment Considerations. Patient preference and adherence, 18, 2159. https://doi.org/10.2147/PPA.S485838

Chicago Style (17th ed.) Citation

B, Varon, Horowitz NA, and Khatib H. "Novel Bispecific T-Cell Engagers for the Treatment of Relapsed B Cell Non-Hodgkin Lymphomas: Current Knowledge and Treatment Considerations." Patient Preference and Adherence 18 (2024): 2159. https://doi.org/10.2147/PPA.S485838.

MLA (9th ed.) Citation

B, Varon, et al. "Novel Bispecific T-Cell Engagers for the Treatment of Relapsed B Cell Non-Hodgkin Lymphomas: Current Knowledge and Treatment Considerations." Patient Preference and Adherence, vol. 18, 2024, p. 2159, https://doi.org/10.2147/PPA.S485838.